Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

Summary

This is an open-label extension study of another study protocol, MCS-2-TWN-a. Subjects who have completed the 12-week treatment and procedures under the protocol MCS-2-TWN-a will be eligible for this study.

Timeline

Start

2010-08

Primary completion

2014-06

Completion

2014-06

Drugs

Indications